An Introduction to inVentiv Health

An Introduction to inVentiv Health
November 2013

Who We Are inVentiv Health, Inc.
13,000 employees in 40 countries, rapidly transforming promising ideas into commercial reality Who We Are inVentiv Health, Inc. is a leading global provider of best-in-class professional services supporting clients in the biopharmaceutical, medical device, and diagnostic markets looking to accelerate performance.

Why We Are Here To respond to the evolving dynamics in the global healthcare market Market Opportunities Market Challenges Demand for healthcare solutions is growing (population, economic growth) Innovation continues to drive change (technology) Increasing complexity/regulation requires greater expertise Price pressure from payers Cost increases (R&D efficiency, regulation) Requirements for differentiated/ measureable outcomes Patent cliff Large “siloed” organizations …The Implications Increasing demand for outsourced solutions Relentless drive for efficiency/effectiveness Increased demand for simplified engagement models—“one-stop shop” Global, global, global Gradual shift toward “outcomes-based” services

What We Bring CLINICAL Commercial Consulting
World class talent and capabilities all in ONE company CLINICAL Commercial Consulting A leading clinical research organization, 2012 CRO of the Year World’s largest provider of healthcare sales, marketing, and communications solutions The leading management consulting group specializing in pharmaceuticals and biotechnology Top 5 CRO Broad portfolio of services Deep therapeutic expertise Late stage/outcomes depth Unique capabilities in patient recruitment Outsourced sales teams and sales support Marketing communications Advertising and public relations Digital communications/social media Public affairs and advocacy Medical education Patient access solutions Patient outcomes, REMS, and Rx access Sample management and compliance Launch planning and support Corporate and business development Corporate, product and portfolio strategies Education and training Market research and analytics Organizational design and improvement Pricing & market access Structured

Supporting Outcomes-Based Solutions Across the Product Lifecycle
Help our clients to accelerate performance, improve outcomes and make lives better worldwide What We Do Supporting Outcomes-Based Solutions Across the Product Lifecycle With more than 40 brands – many standard bearers – inVentiv is known for powering some of the best work in the healthcare industry. We’re intimately familiar with the issues facing the healthcare industry because we support clients across every part of a product’s lifecycle, from the inception of an idea through the development, launch, commercialization and maturity of a medical therapy or device. We have assembled world-class talent within our best-in-class business segments, with global size and scale, offering the services that pharmaceutical, biotechnology, and medical device clients most often require. The real measure of success in any business model is how well it helps clients get the job done. Our leading industry experts can rapidly implement outcomes-based services and design customized solutions that help clients transform promising ideas into reality – quickly, efficiently, seamlessly and cost-effectively.

Where We Work On the ground anytime, anywhere around the world AFRICA
AUSTRALIA Paris, France Deerfield, IL Westerville, OH SOUTH AMERICA Cairo, Egypt Auckland, New Zealand Prague, Czech Republic Irvine, CA Buenos Aires, Argentina Capetown, South Africa Brisbane, Australia Ramsgate, UK Irving, TX Lima, Peru Johannesburg, South Africa Melbourne, Australia Rome, Italy Lake Mary, FL San Isidro, Peru Sydney, Australia St. Petersburg, Russia Lexington, KY Santiago de Chile, Chile ASIA Wellington, New Zealand Stockholm, Sweden Mexico City, Mexico São Paulo, Brazil Bangkok, Thailand The Hague, Netherlands Montreal, Canada Beijing, China EUROPE Vienna, Austria New York, NY Gurgaon, India Antwerp, Belgium Warsaw, Poland Newark, DE Hong Kong, China Athens, Greece Zug, Switzerland Newtown, PA Hyderabad, India Barcelona, Spain Zurich, Switzerland Overland Park, KS Islamabad, Pakistan Berlin, Germany Parsippany, NJ Karachi, Pakistan Bratislava, Slovakia MIDDLE EAST Pointe-Claire, Canada Kuala Lumpur, Malaysia Bucharest, Romania Dubai City, Dubai Princeton, NJ Lahore, Pakistan Budapest, Hungary Jeddah, Saudi Arabia Quebec City, Quebec Mumbai, India Cologne, Germany Ramat Gan, Israel Raleigh, NC Manila, Philippines Dublin, Ireland Riyadh, Saudi Arabia Redmond, WA New Delhi, India Eltville-Martinsthal,Germany San Diego, CA Pune, India Frankfurt, Germany NORTH AMERICA San Francisco, CA Osaka, Japan Freiburg, Germany Ann Arbor, MI San Juan, Puerto Rico Seoul, Korea Istanbul, Turkey Augusta, GA Santa Monica, CA Shanghai, China Kyiv, Ukraine Blue Bell, PA Saratoga Springs, NY Singapore Leusden, Netherlands Boston, MA Somerset, NJ Taipei, Taiwan Lisbon, Portugal Bloomington, MN Southport, CT Tokyo, Japan London, UK Burlington, Canada Tampa, FL Madrid, Spain Burlington, MA The Woodlands, TX Maidenhead, UK Cary, NC Thousand Oaks, CA Milan, Italy Charlotte, NC Toronto, Canada Moscow, Russia Columbus, OH Washington, DC Novosibirsk, Russia Conshohocken, PA West Chester, OH

How We Deliver Clinical Commercial Consulting
Strategic collaboration, shared accountability, delivering extraordinary outcomes All of inVentiv’s services are customizable. We have the ability to combine our best-in-class services and vast resources in numerous possible ways to meet clients’ specific needs. With this flexibility, we help our customers solve complex challenges, deliver extraordinary outcomes, enhance value and improve lives. Clinical Commercial Consulting While clients may purchase our services independently, inVentiv Health can deliver greater value to clients when we combine our best-in-class Consulting, Commercial and Clinical services. Our true differentiator is our ability to converge our resources and know-how, in a variety of ways, to help customers solve complex challenges. We tailor our expertise to specific client needs and collaborate cross-functionally across our Clinical, Commercial and Consulting segments. Working together, our leading industry experts can help clients overcome clinical and regulatory challenges, anticipate commercialization issues and make the most of promising business opportunities. We do what no one else in the marketplace does – a “one-stop shop,” inVenitv does it all from one company. EXAMPLE: inVentiv has invested in new and expanded services in areas such as Phase IV, where we are enhancing our offerings by incorporating both clinical and commercial capabilities to better address our clients' needs. The phase IV market is increasing as companies strive to build better product profiles and establish comparative effectiveness to address increased payer demands and competitive pressures. Our phase IV offering draws on expertise from across our business segments to bring cost-effective solutions and unique insights to the post-approval landscape. EXAMPLE: With a finite number of sites and expanded exclusion criteria, the race is on to engage and secure the best investigators and the right patients for clinical trials. inVentiv’s team of recruitment, retention, and communications specialists understand the nuance and detail required by regulators across all markets, and have the expertise to help drive recruitment and sustain engagement with all key stakeholders. EXAMPLE: inVentiv has developed a proprietary combined commercial services model – known as ReAgentTM – to optimize service execution across multiple brands for its clients. This model leverages a mix of sales, marketing and channel optimization to deliver maximum value to both new and mature brands – improving efficiencies and enhancing profitability. EXAMPLE: To help specialty and biotech companies tackle market access challenges, inVentiv has developed a proprietary offering called EMBARX™. EMBARX brings together services such as strategic consulting, reimbursement support, clinical nursing teams, adherence programs, REMS, outcomes data, and field teams support to improve patient access, increase commercial value, and drive adherence and loyalty to our clients’ products.

Why inVentiv One strategic partner focused on making a difference
Best-in-Class Capabilities World-Class Talent Global Scale Operational Excellence Customized Solutions Unique Insights & Analytics Our Results Top-five clinical research organization #2 healthcare communications firm Largest provider of outsourced healthcare sales forces in the US (second largest in Japan) Largest recruiter of clinical and pharma sales people in world Assisted over 2 million patients with gaining access to medication Launched the first Facebook page for a branded drug; launched the first branded pharma campaign on Twitter Has over 120 million patient prescription records (Think Analytics!) Worked on naming for more than one third of the approved drugs since 2008 Generated over $1 billion of incremental revenue (for clients) in last three years through increased compliance

Clinical Development Services

inVentiv Health Clinical Overview
Industry leader Top 5 global CRO Significant global footprint - more than 6,000 employees, offices in 32 countries, operating in over 70 countries Diversified services across the product development continuum Complete product development capabilities in Phase I-Late Stage Services Customized to the way you outsource: Staff Augmentation, Staffed Groups, Functional Service Provider, Full Service Programs, and/or Strategic Relationships inVentiv Commercial and Consulting expand service offering from clinical to commercialization strategies, product branding, marketing, and sales Depth of therapeutic, medical, clinical, regulatory and scientific expertise 168 MD and 160 PhD staff members across the organization Therapeutically-aligned teams International regulatory expertise

inVentiv Health Clinical Network
7,000 Employees operating in over 70 Countries Dedicated to Clinical Research inVentiv Health Clinical Network NORTH AMERICA EUROPE ASIA PACIFIC FIELD-BASED Ann Arbor, MI Barcelona, ES Auckland, NZ Brisbane, AU Basking Ridge, NJ Berlin, DE Bangkok, TH Brussels, BE Blue Bell, PA Bratislava, SK Providencia Santiago, CL Beijing, CN Paris, FR Burlington, ON Bucharest, RO Gurgaon, IN Ramat Gan, IE Cary, NC Eltville-Martinsthal, DE Hong Kong, CN Chicago, IL Frankfurt, DE Hyderabad, IN Wellington, NZ Deerfield, IL Gravenhage, NL Kuala Lumpur, MY San Isidro, PE Lake Mary, FL Kusnacht, CH Makati City, PH Johannesburg, ZA Montreal, QC Kyiv, UA Mumbai, IN Belgrade, Serbia New York, NY Leusden, NL Pune, IN Princeton, NJ Madrid, ES Seoul, KR Zagreb, HR Quebec City, QC Maidenhead, UK Sofia, BG Shanghai, CN Budapest, HU San Diego, CA Milan, IT Singapore, SG Copenhagen, DK Somerset, NJ Moscow, RU Sydney, AU San Jose, CR Tampa, FL Nanterre, FR Taipei, TW West Valley City, UT Neu-Isenburg, DE Tokyo, JP Novosibirsk, RU LATIN AMERICA Prague, CZ Buenos Aires, AR Ramsgate, UK Lima, PE Rome, IT Mexico City, MX St. Petersburg, RU Santiago, CL Stockholm, SE Sao Paulo, BR Warsaw, PL

Clinical Organization
Raymond Hill President, inVentiv Clinical Cynthia Osborne Executive Assistant Riaz Bandali President, Early Stage Dawn Anderson President, Phase II-IV Gregg Dearhammer President, Strategic Resourcing Marty Birkhofer Chief Medical Officer Gregory Skalicky Exec. VP, Business Development Rick Shimota Chief Financial Officer MJ Carino Sr. VP Human Resources Joe Fortunato Sr. VP, Quality Assurance Ramita Tandon Sr. VP & GM Patient Outcomes Joseph Tetzlaff Chief Information Officer David Peters VP, Communications & Corporate Development Eric Sherbert General Counsel

Early Stage Development
Riaz Bandali President, Early Stage Susanne Gosselin Executive Assistant George Scott VP, Bioanalytical Services Zohar Bassevitch Sr. Director, PM & CP Catherine Derasp VP, Clinical Operations Mario Tanquay VP, Clinical Pharmacology

Phase II-IV Development
Dawn Anderson President, Phase II-IV Gregory Hockel Exec. VP, Regulatory Affairs Jeanne Ashton Sr. VP, Global Data Services Alison O’Neill Sr. VP, Global Therapeutic & Clinical Operations, NA Sue Stansfield Exec. VP, Clinical Operations, Phase II-IV Jeffrey Trotter Exec. VP, Late Stage Kriszta Varga-Cox Supervisor, Admin. Services

Strategic Resourcing Gregg Dearhammer President, Strategic Resourcing
Linda Kemnitz Executive Assistant Maria Smith Sr. Director, Grants & Contracts Malinda Irelan Executive Assistant Curt Esper Facilities Specialist Ann Pongracz Director, Medical Writing Barbara Goranson Director, Strategic Resourcing Prashant Kirkire Sr. Director, Operations Diana Cucos VP, Strategic Resourcing Mark Cooper VP, Strategic Resourcing Marty Anderson VP, Strategic Resourcing Tracy Mayer VP, Strategic Resourcing Amy Meszaros VP, Strategic Resourcing Brenda Hoeper Sr. VP, Strategic Resourcing Jeff Noll Manager, Recruiting Mishka Symonette Exec. Director, Recruiting Sara Gordon VP, Communications & Corporate Development Brian Nelson Director, Global Recruitment Center

Business Development Gregory Skalicky Exec. VP, Business Development
Diana Petrone Executive Assistant Daniel Smith Sr. VP, Business Development Jason Casarella VP, Business Development Michael Ryan VP, Business Development, Phase II-IV Farah Ahmad VP, Business Development Fernando Martinez VP, Business Development, EMEA & APAC Angela Russian Exec. Director, Business Development Andy Malavsky Exec. Director, Marketing Brian McAllister Sr. Director, Business Development

Human Resources MJ Carino Sr. VP, Human Resources
Jeanne Fisher HR Associate Rosemary McGuire VP, Human Resources Michelle Johnson Exec. Director, Human Resources Donna Elbert VP, Human Resources

Patient Outcomes Ramita Tandon Sr. VP & GM Patient Outcomes Jill Guary
Erica Rascov Sr. Feasibility Associate Brent Peterson Sr. Feasibility Associate Halina Filipowicz Sr. Feasibility Associate

Communication & Corporate Development
David Peters Sr. VP, Communication & Corporate Development Michael McDevitt Sr. Director, Clinical Data Programming Ruth Boone Sr. Financial Analyst Gary Leach Financial Analyst Alison Leaver Sr. Data Services Trial Leader Nicholas Jackson Dr. Metrics & Process Optimization

General Counsel Eric Sherbert General Counsel
Susan Lipsitz Assoc. General Counsel Jesse Moore Assoc. General Counsel Valarie Palumbo Sr. VP, Corporate Quality Assurance Charles Jewell Assoc. General Counsel Lisa Hieb Assoc. General Counsel

Learning Development Open Position Learning & Development
Nancy Connell VP, Learning & Development

Clinical Introduction
Phase I/Bioequivalence Bioanalytical Services Phase II-III Phase IV All Phases Full Service Strategic Resourcing Phase I Studies First in Human Special Populations Thorough QTc Drug Interactions Generics Bioavailability Bioequivalence High-end Generics Clinical Laboratory Pharmacokinetic Analysis Scientific Affairs and Reporting Capabilities 1 clinic with over 22,000 sq ft 4 clinical wards with 200 beds Sample Handling Method Development and Validation Sample Analysis Discovery Support Small Molecule: LC/MS/MS GC/MS/MS Biomarkers Large Molecule: ELISA and RIA, Ligand Binding Cell-based Assays Immunogenicity Assays Biomarkers 1000+ validated assays ~900,000 samples analyzed per year 2 labs with over 44,000 sq ft Biostatistics Clinical Development Planning Data Management Medical Monitoring and Oversight Medical Writing Patient Recruitment Project Management Site Management Study Monitoring International Regulatory Consultation/Operations Medical/Scientific Consultation Staff Augmentation Staffed Groups Functional Service Provider Strategic Alliances Clinical Monitoring Pharmacovigilance Clinical Staffing Product Selection Risk Management and Development Pharmacoeconomics Product Launch Support Programs Drug-Utilization Strategies Patient Outcome Studies Disease Management Brand Expansion Strategies for Competitiveness Technology Project Management Information System Study Supply Management Randomization Electronic Data Capture PKS Expertise with all major clinical trial databases Investigator Database Electronic Trial Master File Electronic Regulatory Submissions Perceptive Informatics ‘ Initiator

Phase I and Bioequivalence Services
Accelerating Drug Development 15 years of Phase I drug development in a wide variety of therapeutic areas and dosage forms Conducted hundreds of studies; file more than 200 CTAs/year Full suite of services ranging from protocol design to study report preparation Diverse study and therapeutic experience Outstanding project management skills comprised of with medical and scientific experts to ensure volunteer safety Regulatory expertise, medical writing, biostatistics, pharmacokinetics experts Extensive experience working with FDA, EMA, Heath Canada, and European- based agencies Expedited Phase I studies Mitigate risk with a professional and skilled team Rapid recruitment Streamlined study execution State of the art data management technologies ensure fast, accurate reporting for real time decision making Mitigate risk with a professional and skilled team 22,000 square foot clinical facility with 200 beds divided into 4 units Clinical lab, on-site pharmacy Partnerships with local hospitals

Bioanalytical Services: Market-leading Small, Large Molecule Scientific Expertise
This is how inVentiv Health Clinical transforms promising ideas into commercial reality: Scientific Expertise 18+ years of experience in method development, validation and analysis Over 1000 assays and biomarkers methods available Two GLP facilities with state-of-the art instrumentation Rapid Analysis and Large Capacity of Small Molecule One of the largest capacities of any bioanalytical lab Largest suite of mass specs in the industry Rapid turnaround times Expertise in Large Molecules Scientific expertise in a wide variety of large molecule projects Scientific leadership to address more complex projects including novel compounds High capacity Risk Management through quality and compliance Project Management Robust Sample management process Outstanding quality and compliance and regulatory expertise

Integrated, Full-Service Phase II-III Product Development Expertise
Comprehensive Development Services Biostatistics, Data Management and Statistical Programming Clinical Monitoring, Project Management and Strategic Oversight Patient and investigator recruitment Mitigate Risk with a Professional and Skilled Team Clinical development planning and expert project management International regulatory consulting Medical/scientific Specialization in Therapeutic Areas Therapeutically aligned leadership with strong product development experience and background Integrated teams deliver technical, operational and therapeutic expertise for lifecycle management Rapid Patient Recruitment Trial feasibility and site selection, site approvals Patient recruiting strategy Access to claims data of 90 million patients in the US

Specialization in Core Therapeutic Areas
Therapeutically aligned leadership with strong product development experience and background Fully integrated teams to deliver technical, operational and therapeutic expertise Therapeutically aligned site selection and patient recruitment expertise Other specialty areas: Pediatrics >80 Studies Phase IV >195 Studies Therapeutic Area of Focus Trials Hematology and Oncology >370 Neuroscience >430 General Medicine >300 Infectious Disease >260 Cardiology, Endocrinology, Metabolic disease >230 Pain and Inflammatory Disease >150

Phase IV Services: Bridging the Gap Between Development and Commercialization
Observational/non-interventional Retrospective research Label extension trials Expanded access studies Post-approval safety surveillance Epidemiology Patient-reported outcomes Comprehensive Phase IV Services Real world experience, real value Pragmatic, scientifically sound, trial design and operational cost-efficiency Proactive Recruitment inVentiv Physician Network provides access to investigators dedicated to observational and non-interventional research and patients Part of the Expert inVentiv network Part of expert inVentiv network dedicated to safe and effective commercialization, including ParagonRx (REMS) and Campbell Alliance (consulting, CER)

Custom Resourcing Solutions
Flexible/Scalable Resourcing More than 3,000 people working in 30 countries Combines strength of FSP with industry leading staffing capabilities Worked with over 160 companies-suite of services ranging from staff augmentation to strategic partnerships Experienced FSP Partner 46 active FSPs, 25 clients including Top 5 and 10 Pharma Dedicated teams in all functions/phases can achieve up to 30% savings Staff lift outs/asset transfer can yield huge savings for clients Worldwide Staffing Resources 12 managed staffing relationships, 9 unique clients 40+ years combined experience in US, EU, Asia and Latin America Contract or permanent staffing, internal teams, FSPs Database of ~200,000 candidates worldwide with broad therapeutic and functional expertise Industry-leading retention rates

Therapeutically-aligned Expertise
Developed over 12 years Dedicated staff for each division Physicians within TA Senior leaders (20+ years) Project managers (10+ years) CRA alignment All geographic regions Hematology & Oncology Vaccines/ ID & Respiratory Resources become experts within a core therapeutic area Neuroscience Operational efficiency Scientific quality Site, KOLs, and regulatory relationships Engaged and informed management Pain - Inflammation Cardiovascular - Metabolic General Medicine 29

Therapeutically-aligned Expertise Oncology
Unique inVentiv advantages The Navicor Group, an InVentiv Company Dedicated Phase 1 team Substantial specialization in breast cancer Expertise in rare hematologic malignancies 11 recent NDA/sNDA approvals Oncology Trials 381 last 5 years (all services) 251 Clinical > 8,900 sites > 61,000 patients Solid tumors 156 last 5 years 8,700 sites 66,000 patients Hematologic 95 last 5 years 4,065 sites 30,750 patients 30

Therapeutically-aligned Expertise Neuroscience
Unique inVentiv advantages Partnership for Phase 1 disease state Integrated Rater Training services Scale licensing and translation Staff have served as PI, site coordinators (especially AD) Psychologists on team (including neuropsychologists) 8 recent NDA/sNDA approvals Neuroscience Trials 345 last 5 years (all services) 146 Clinical > 5,900 sites > 44,300 patients 31

Therapeutically-aligned Expertise Pain and Inflammation
Unique inVentiv advantages More than 50 RA/OA trials Post-surgical experience Drug - Device combinations Manage scheduled substances Pain and Inflammation Trials 153 trials last 5 years (all services) 106 clinical > 6,800 Sites > 39,400 Patients 32

Therapeutically-aligned Expertise Cardiovascular and Metabolism
Unique inVentiv advantages Imaging including IVUS Hospital based-studies Endpoint management Pediatric and adolescent CV/Metabolism Cardiovascular and Metabolism Trials 247 last 5 years (all services) 123 Clinical > 7,300 Sites > 67,300 Patients 33

Therapeutically-aligned Expertise Vaccines and Infectious Disease
Unique inVentiv advantages Cold chain process Bio-terrorism research Government funded (DoD, HHS, BARDA) Vaccine network Site capacity building/TB Strategic partnership experience ID/Vaccine and Respiratory ID/ Vaccine Trials 186 last 5 years (all services) 87 Clinical > 3,200 Sites > 60,300 Patients 34

Therapeutically-aligned Expertise General Medicine
Dermatology Gastroenterology Nephrology/Urology Ophthalmology Rare Diseases Transplant Women’s Health Unique inVentiv advantages Dialysis site networks Home health network Hospital-based study experience Stem cell research Significant orphan drug/rare disease experience General Medicine Trials 260 last 5 years (all services) 140 Clinical > 6,000 Sites > 62,500 Patients 35

Therapeutically-aligned Expertise Pediatrics
Cardiovascular Dermatology Endocrinology & Metabolism Gastroenterology Hematology & Oncology Infectious Disease/Vaccines Neuroscience Rare Diseases Respiratory Pediatrics Trials 110 last 5 years (all services) 72 Clinical > 2,400 Sites > 34,200 Patients Unique inVentiv advantages Consulting of the European Pediatric legislation and the US FDA PREA and BPCA Acts Pediatric Investigational Plans (PIPs) Experience with pediatric investigators Pediatric Informed Consent Consulting on age appropriate formulations and toxicity testing 36

Feasibility and Patient Recruitment/Retention
World class, comprehensive services

Investigator and Patient Strategies
inVentiv Clinical’s protocol feasibility, site selection and patient recruitment strategies are driven by data and analytics Ensures an effective and efficient approach to securing and retaining both investigators and patients

Investigator and Patient Strategies
Our extensive experience managing and conducting global assessments includes: Greater than 1,100 total patient recruitment and retention projects spanning 170+ indications >90 countries globally, >200 feasibility and site identification programs annually Aggregated wealth of historical performance data and investigator- reported information to build a data asset that can better prioritize investigator sites Run algorithms against the data to identify the right number of the most effective investigators Increases the number of high-performing sites to meet trial timelines Best practices approach involves thorough analysis of the study design as well as ideal patient and investigator profiles

Data Driven Analysis and Planning
We maintain exclusive access to United Health Group integrated claims database reports Captures140 million covered lives inclusive of Commercial, Medicare and Medicaid populations Longitudinal dataset is mined using ICD-9, CPT, NDC codes and FDA BMIS records Specific to indication and protocol criteria, information related to physician treatment patterns, research experience, and patient health care are assessed Key applications Identifies ideal physician profiles (location, name, practice, etc) - who is treating, to what degree they treat, research experience, specialty Gives broader community and referring physician pool Data findings are then applied/extrapolated globally

Data Driven Analysis and Planning
Adheris, an inVentiv Health company, database contains rich and real- time prescription data for more than 120 million patients Largest, direct-to-patient (DTP) database for HIPAA compliant, clinical trial patient recruitment Provides proprietary access to patient and prescription level, plus disease and physician profile data including the following: Patient demographics Product daily dose, formulation and strength Six years of treatment history Physician demographics, practice characteristics Identify prospective clinical trial candidates in a faster, more effective DTP manner for efficient outreach

Our Step-by-Step Approach to Designing the Plan
OUR APPROACH Our Step-by-Step Approach to Designing the Plan 1. Understand the recruitment and environmental challenges All our programs are based on a detailed assessment of the challenges to deliver only the most-effective, evidence-based solutions. 2. Identify and understand our stakeholders and their drivers for participation 3. Understand how, when and where to engage/integrate with patients, HCPs and other stakeholders 4. Create a powerful visual identity that resonates across all stakeholders 5. Target the right messages to the right stakeholders at the right time; measure and analyze

One strategic partner supporting clients through every phase of the product life cycle
Why inVentiv Health? Best-in-Class Capabilities Innovative solutions based upon industry-wide experience Global Scale Operations in more than 40 countries World-Class Talent 13,000 employees across three business segments Operational Excellence Ability to make decisions and deploy resources rapidly Customized Solutions Seamless ability to scale up or down as needed Rigorous Analytics Proven methodologies applied across the lifecycle Unique Insights Strategic lens applied to tactical know-how Around the world, inVentiv supports clients through every part of a product’s lifecycle, from the inception of an idea through the development, launch, commercialization and maturity of a medical therapy or device.

An Introduction to inVentiv Health

Similar presentations

Presentation on theme: "An Introduction to inVentiv Health"— Presentation transcript:

Similar presentations

About project

Feedback

Log in

Auth with social network:

An Introduction to inVentiv Health

Similar presentations

Presentation on theme: "An Introduction to inVentiv Health"— Presentation transcript:

Similar presentations

About project

Feedback